verified SJR 0,852 · Q2 • database Scopus / SJR & Web of Science indexed

Switzerland · S. Karger AG

workspace_premium Q2 — Neurology (clinical) lock Subscription

Neurodegenerative Diseases

Neurodegenerative Diseases is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 70. It has an SJR impact factor of 0,852 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,852.

ISSN: 1660-2854

Publisher: S. Karger AG

Category: Neurology (clinical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,852 Q2

H-index 70

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,852

H-index

Docs (year)

Docs 3y

Total refs

760

Cites 3y

154

Citable 3y

Cites/Doc 2y

2.29

Ref/Doc

40.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Breakdown of Sensorimotor Network Communication in Leukoaraiosis

Voxel-Based Morphometry in Tau-Positive and Tau-Negative Frontotemporal Lobar Degenerations

Downregulation of beta-Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein: Proteomics-Based Identification in Early-Stage Prion Disease

Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study

Course of Irritability, Depression and Apathy in Huntington's Disease in Relation to Motor Symptoms during a Two-Year Follow-Up Period

Cortical Brain Biopsy in Long-Term Prognostication of 468 Patients with Possible Normal Pressure Hydrocephalus

Complexity of Astrocyte-Motor Neuron Interactions in Amyotrophic Lateral Sclerosis

Common Variant inGRNIs a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly

Cognitive Event-Related Potentials and Oscillations in the Subthalamic Nucleus

Clinical and Molecular Aspects of Frontotemporal Dementia

Challenges of Longevity in Developed Countries: Vascular Prevention of Dementia as an Immediate Clue to Tackle an Upcoming Medical, Social and Economic Stretch

Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Families with PSEN1 Mutations

SHOW MORE ARTICLES

Campath-1H Treatment of Multiple Sclerosis

A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier

Biomarkers for the Early Detection of Parkinson's and Alzheimer's Disease

beta-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine

BACE1 and Presenilin: Two Unusual Aspartyl Proteases Involved in Alzheimer's Disease

BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation

Axonal Degeneration in Motor Neuron Disease

Assessment of the Bioactivity of Antibodies against beta-Amyloid Peptide in vitro and in vivo

APP Processing and the APP-KPI Domain Involvement in the Amyloid Cascade

Anti-Neuronal Antibodies in Patients with Fragile X Syndrome: Is there a Role of Autoimmunity in Its Pathogenesis?

An Exploratory Study on the CHRNA3-CHRNA5-CHRNB4 Cluster, Smoking, and Parkinson's Disease

An Astrocyte Regenerative Response from Vimentin-Containing Cells in the Spinal Cord of Amyotrophic Lateral Sclerosis's Disease-Like Transgenic (G93A SOD1) Mice

FAQs

Neurodegenerative Diseases has an SJR of 0,852 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Neurodegenerative Diseases is 29%.

Neurodegenerative Diseases

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Neurodegenerative Diseases?

What is the APC / publication cost?

What is the acceptance rate?